↓ Skip to main content

Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease

Overview of attention for book
Cover of 'Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Introduction and Technical Survey: Protein Aggregation and Fibrillogenesis
  3. Altmetric Badge
    Chapter 2 Fibril Formation by Short Synthetic Peptides
  4. Altmetric Badge
    Chapter 3 In vitro Oligomerization and Fibrillogenesis of Amyloid-beta Peptides
  5. Altmetric Badge
    Chapter 4 Tau Fibrillogenesis
  6. Altmetric Badge
    Chapter 5 Prion Protein Aggregation and Fibrillogenesis In Vitro
  7. Altmetric Badge
    Chapter 6 α-Synuclein Aggregation and Modulating Factors
  8. Altmetric Badge
    Chapter 7 Pathological Self-Aggregation ofb 2 -Microglobulin: A Challenge for Protein Biophysics
  9. Altmetric Badge
    Chapter 8 Islet Amyloid Polypeptide: Aggregation and Fibrillogenesisin vitroand Its Inhibition.
  10. Altmetric Badge
    Chapter 9 Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease
  11. Altmetric Badge
    Chapter 10 Fibrillogenesis of Huntingtin and Other Glutamine Containing Proteins
  12. Altmetric Badge
    Chapter 11 Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease
  13. Altmetric Badge
    Chapter 12 Experimental Inhibition of Peptide Fibrillogenesis by Synthetic Peptides, Carbohydrates and Drugs
  14. Altmetric Badge
    Chapter 13 Experimental Inhibition of Fibrillogenesis and Neurotoxicity by amyloid-beta (Aβ) and Other Disease-Related Peptides/Proteins by Plant Extracts and Herbal Compounds
  15. Altmetric Badge
    Chapter 14 Alzheimer's disease.
  16. Altmetric Badge
    Chapter 15 Modeling the Polyglutamine Aggregation Pathway in Huntington’s Disease: From Basic Studies to Clinical Applications
  17. Altmetric Badge
    Chapter 16 Parkinson’s Disease
  18. Altmetric Badge
    Chapter 17 Human prion diseases: from kuru to variant creutzfeldt-jakob disease.
  19. Altmetric Badge
    Chapter 18 Animal prion diseases.
  20. Altmetric Badge
    Chapter 19 β(2)-Microglobulin Amyloidosis.
  21. Altmetric Badge
    Chapter 20 Systemic AA Amyloidosis
  22. Altmetric Badge
    Chapter 21 Familial amyloidotic polyneuropathy and transthyretin.
  23. Altmetric Badge
    Chapter 22 The Challenge of Systemic Immunoglobulin Light-Chain Amyloidosis (AL)
Attention for Chapter 18: Animal prion diseases.
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
31 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Animal prion diseases.
Chapter number 18
Book title
Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease
Published in
Sub cellular biochemistry, December 2012
DOI 10.1007/978-94-007-5416-4_18
Pubmed ID
Book ISBNs
978-9-40-075415-7, 978-9-40-075416-4
Authors

Windl O, Dawson M, Otto Windl, Mike Dawson, Windl, Otto, Dawson, Mike

Abstract

Prion diseases occur in many animal species, most notably in ruminants. While scrapie in sheep has been recognised for three centuries and goat scrapie has been recognised for decades, BSE in cattle is a relatively novel disease which was first diagnosed in the UK in the mid 1980s. BSE was most likely caused through dietary exposure to animal feed contaminated with prions and disease was subsequently transmitted to people. The BSE epidemic is almost at an end, but the recent identification of so called atypical forms of BSE and scrapie pose many questions about the possible spectrum of prion diseases in animals and their transmissibility to other species, including humans.The pathogenesis of animal prion diseases has been studied both in natural infections and in experimental animal models. Detection of infectivity is greatly helped by suitable rodent models, in particular transgenic mice. Clinically infected animals show characteristic neuropathology in the brain and spinal cord which is accompanied by the accumulation of a conformationally altered, protease-resistant host protein. The post-mortem diagnosis is based on the detection of this protein, PrP(Sc), but despite recent impressive developments a routine ante-mortem diagnostic test has proved elusive.There is no treatment for prion diseases in animals, but disease outbreaks are controlled through a mixture of movement restrictions on holdings, culling of affected animals and herds and, for classical scrapie in sheep, selective breeding for genetic resistance. Prions are very stable and can remain in the environment for prolonged periods. This poses serious practical questions with regard to the decontamination of infected premises. The control of BSE specifically through restrictions in animal feeding practises has been successful, but the changing spectrum of these diseases plus the economic pressures to relax feed bans and reduce levels of surveillance will require constant vigilance to safeguard animal and public health.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
France 1 3%
Unknown 30 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 23%
Student > Ph. D. Student 6 19%
Student > Master 2 6%
Student > Bachelor 2 6%
Other 2 6%
Other 6 19%
Unknown 6 19%
Readers by discipline Count As %
Agricultural and Biological Sciences 7 23%
Biochemistry, Genetics and Molecular Biology 6 19%
Veterinary Science and Veterinary Medicine 3 10%
Medicine and Dentistry 3 10%
Chemistry 2 6%
Other 4 13%
Unknown 6 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 December 2012.
All research outputs
#15,260,208
of 22,691,736 outputs
Outputs from Sub cellular biochemistry
#183
of 350 outputs
Outputs of similar age
#180,040
of 278,838 outputs
Outputs of similar age from Sub cellular biochemistry
#14
of 19 outputs
Altmetric has tracked 22,691,736 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 350 research outputs from this source. They receive a mean Attention Score of 4.7. This one is in the 37th percentile – i.e., 37% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 278,838 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.